Page last updated: 2024-08-18

xanthenes and Alzheimer Disease

xanthenes has been researched along with Alzheimer Disease in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghahsare, AG; Nazifi, SMR; Nazifi, ZS1
Jha, AB; Panchal, SS; Shah, A1
Amegadzie, A; Bartberger, MD; Brown, J; Chen, JJ; Chen, K; Cheng, AC; Cheng, Y; Dineen, TA; Dunn, RT; Epstein, O; Everds, NE; Fremeau, RT; Gore, V; Hickman, D; Hitchcock, SA; Human, J; Judd, TC; Kreiman, C; Liu, Q; Lopez, P; Ma, V; Marx, I; Minatti, AE; Patel, VF; Powers, TS; Qian, W; Vargas, HM; Vonderfecht, SL; Weiss, MM; Wen, PH; Werner, JA; White, RD; Whittington, DA; Wood, S; Xue, M; Yuan, C; Zhong, W1
Albargothy, NJ; Carare, RO; Gatherer, M; Hawkes, C; Morris, A; Sharp, MM; Weller, RO1
Burton, MA; Duong, S; Goldstein, LE; Hyman, B; Ingelsson, M; Kirby, JE; Moir, RD; Soscia, SJ; Tanzi, RE; Tucker, SM; Washicosky, KJ1
Ehrlich, ME; Fraser, PE; Gandy, S; Kim, SH; St George-Hyslop, PH; Westaway, D1
Battaglia, G; Britton, TC; Bruno, V; Cannella, M; Caraci, F; Copani, A; Drago, F; Giuffrida, ML; Heinz, BA; Merlo, S; Molinaro, G; Nicoletti, F; Nisenbaum, ES; Riozzi, B; Sortino, MA; Traficante, A; Wang, X1
Chen, K; Cheng, AC; Dineen, TA; Epstein, O; Fremeau, RT; Graceffa, R; Hickman, D; Huang, H; Kiang, YH; La, DS; Louie, S; Luo, Y; Patel, VF; Wahl, RC; Wen, PH; Whittington, DA; Wood, S1
Berezov, T; Boldyrev, A; Carpenter, DO; Koudinov, A1
Du, G; Li, Z; Ni, K1
Bondareff, W; Harrington, C; Hauser, DL; Roth, M; Wischik, CM1

Reviews

1 review(s) available for xanthenes and Alzheimer Disease

ArticleYear
Structure-Bioactivity Relationship Study of Xanthene Derivatives: A Brief Review.
    Current organic synthesis, 2019, Volume: 16, Issue:8

    Topics: Alzheimer Disease; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Products; Drug Compounding; Drug Design; Humans; Hypoglycemic Agents; Molecular Structure; Structure-Activity Relationship; Xanthenes

2019

Other Studies

10 other study(ies) available for xanthenes and Alzheimer Disease

ArticleYear
Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease.
    Pharmacology, biochemistry, and behavior, 2018, Volume: 175

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Cognition; Donepezil; Ellagic Acid; Female; Free Radical Scavengers; Humans; Male; Maze Learning; Molecular Docking Simulation; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Xanthenes

2018
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease.
    Bioorganic & medicinal chemistry letters, 2015, Feb-15, Volume: 25, Issue:4

    Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cell Line; HEK293 Cells; Humans; Protease Inhibitors; Rats; Xanthenes

2015
Investigating the Lymphatic Drainage of the Brain: Essential Skills and Tools.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1559

    Topics: Alzheimer Disease; Animals; Cisterna Magna; Extracellular Fluid; Fixatives; Fluorescent Dyes; Formaldehyde; Hippocampus; Humans; Immunohistochemistry; Injections, Intraventricular; Lymphatic Vessels; Mice; Microscopy, Fluorescence; Parenchymal Tissue; Perfusion; Polymers; Stereotaxic Techniques; Tissue Embedding; Xanthenes

2017
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
    PloS one, 2010, Mar-03, Volume: 5, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Antimicrobial Cationic Peptides; Brain; Candida albicans; Cathelicidins; Cell Survival; Environment; Humans; Immunity, Innate; Inflammation; Ligands; Microbial Sensitivity Tests; Oxazines; Recombinant Proteins; Xanthenes

2010
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Mar-17, Volume: 30, Issue:11

    Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Humans; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Nerve Endings; Peptide Fragments; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes

2010
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 an
    Molecular pharmacology, 2011, Volume: 79, Issue:3

    Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Antipsychotic Agents; Astrocytes; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Psychotic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Transforming Growth Factor beta1; Xanthenes

2011
Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.
    Journal of medicinal chemistry, 2012, Nov-08, Volume: 55, Issue:21

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Cell Line; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Molecular Structure; Oxazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Xanthenes

2012
Amyloid-beta induced cell death is independent of free radicals.
    Journal of Alzheimer's disease : JAD, 2004, Volume: 6, Issue:6

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Newborn; Calcium; Carnosine; Cell Death; Cell Survival; Cerebellum; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; Free Radicals; Indicators and Reagents; Intracellular Space; Kainic Acid; N-Methylaspartate; Neurons; Propidium; Rats; Reactive Oxygen Species; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xanthenes

2004
[Simultaneous analysis of six effective components in the anti-Alzheimer's disease effective component group of Xiao-Xu-Ming Decoction].
    Se pu = Chinese journal of chromatography, 2007, Volume: 25, Issue:1

    Topics: Alzheimer Disease; Animals; Benzoates; Benzylisoquinolines; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Flavonoids; Glucosides; Monosaccharides; Monoterpenes; Xanthenes

2007
Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease.
    Journal of neuropathology and experimental neurology, 1994, Volume: 53, Issue:2

    Topics: Alzheimer Disease; Antibodies; Epitopes; Fluorescein-5-isothiocyanate; Hippocampus; Humans; Immunohistochemistry; Microscopy; Nerve Degeneration; Neurofibrillary Tangles; Pronase; tau Proteins; Xanthenes

1994